Prospective audit and feedback implementation by a multidisciplinary antimicrobial stewardship team shortens the time to de-escalation of anti-MRSA agents

Prospective audit and feedback (PAF) is considered an effective procedure for appropriate antibiotic use. However, its effect on the time to de-escalation is unclear. We aimed to evaluate the effect of daily PAF implementation, focusing on the time to de-escalation of anti-methicillin‐resistant Staphylococcus aureus (MRSA) agents as an outcome measure. To this end, a single-center, retrospective, quasi-experimental study including patients treated with intravenous anti-MRSA agents during pre-PAF (April 1, 2014 to March 31, 2015) and post-PAF (April 1, 2015 to March 31, 2016) periods was conducted. The time to de-escalation was estimated using the Kaplan–Meier method, and Cox proportional hazard analysis was performed to assess the effect of daily PAF implementation on the time to de-escalation. Interrupted time series analysis was used to evaluate the relationship between daily PAF implementation and anti-MRSA agent utilization data converted to defined daily dose (DDD) and days of therapy (DOT) per 1,000 patient days. The median time to de-escalation was significantly shorter in the post-PAF period than in the pre-PAF period (6 days vs. 7 days, P < 0.001). According to multivariate analysis, PAF implementation was independently associated with a shorter time to de-escalation (hazard ratio [HR], 1.18; 95% confidence interval [CI], 1.02 to 1.35). There were no significant differences in hospital mortality, 30-day mortality, and length of stay between the two periods. Interrupted time series analysis showed significant reductions in the trends of DDD (trend change, –0.65; 95% CI, –1.20 to –0.11) and DOT (trend change, –0.74; 95% CI, –1.33 to –0.15) between the pre-PAF and post-PAF periods. Daily PAF implementation for patients treated with intravenous anti-MRSA agents led to a shorter time to de-escalation and lower consumption of anti-MRSA agents without worsening the clinically important outcomes.

[1]  V. Luther,et al.  Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program , 2016, BMC Infectious Diseases.

[2]  A. Cheng,et al.  The impact of a multidisciplinary antimicrobial stewardship team on the timeliness of antimicrobial therapy in patients with positive blood cultures: a randomized controlled trial. , 2016, The Journal of antimicrobial chemotherapy.

[3]  K. Iwata,et al.  Is de-escalation of antimicrobials effective? A systematic review and meta-analysis. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  Matthew H Samore,et al.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Timsit,et al.  A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  K. Rand,et al.  Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. , 2016, Diagnostic microbiology and infectious disease.

[7]  T. Wilt,et al.  Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review , 2014, Infection Control &#x0026; Hospital Epidemiology.

[8]  D. Livermore,et al.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia , 2013, Haematologica.

[9]  C. Diazgranados.  Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes. , 2012, American journal of infection control.

[10]  S. Cosgrove,et al.  Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Rachlis,et al.  Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis , 2012, Infection Control &#x0026; Hospital Epidemiology.

[12]  Bryan C. Knepper,et al.  Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess. , 2011, Archives of internal medicine.

[13]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Decruyenaere,et al.  De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? , 2010, Journal of critical care.

[15]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Joshua A. Doherty,et al.  A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. , 2007, Clinical therapeutics.

[17]  A K Wagner,et al.  Segmented regression analysis of interrupted time series studies in medication use research , 2002, Journal of clinical pharmacy and therapeutics.

[18]  D. Gerding.  The search for good antimicrobial stewardship. , 2001, The Joint Commission journal on quality improvement.

[19]  Organización Mundial de la Salud.  Guidelines for ATC classification and DDD assignment , 1996 .

[20]  M. Weinstein,et al.  Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. , 1993, Diagnostic microbiology and infectious disease.

[21]  P. C. Migneault,et al.  Time to detection of positive BacT/Alert blood cultures and lack of need for routine subculture of 5- to 7-day negative cultures , 1992, Journal of clinical microbiology.

[22]  P. Mackowiak.  Drug fever: mechanisms, maxims and misconceptions. , 1987, The American journal of the medical sciences.